Results 31 to 40 of about 9,858 (221)
Factors associated with failure of using high flow nasal cannula in children
The Clinical Respiratory Journal, 2022 Introduction High flow nasal cannula (HFNC) has significantly success in treating acute respiratory distress while HFNC failure dramatically increases mortality and morbidity. Objective To describe factors associated with failure of HFNC use in children.
Kanokkarn Sunkonkit +3 more
doaj +1 more source
Changes in respiratory variables of patients during HFNC (N = 133).
, 2022 Changes in respiratory variables of patients during HFNC (N = 133).
Bo Young Lee (3364223) +7 more
core +1 more source
Mean values before, during and after treatment with the HFNC.
, 2022 Mean values before, during and after treatment with the HFNC.
Pieter Veenstra (13911597) +4 more
core +1 more source
BMJ Open Respiratory Research, 2021 Background To assess the published evidence to establish the efficacy and safety of high flow oxygen cannula (HFNC) as respiratory support for children up to 24 months of age with bronchiolitis within acute hospital settings.Methods We searched eight ...
Sarah J Kotecha +3 more
doaj +1 more source
Treatable traits for HFNC in included COPD-patients.
, 2022 Treatable traits for HFNC in included COPD-patients.
Pieter Veenstra (13911597) +4 more
core +1 more source
The Outcome Impact of Early vs Late HFNC Oxygen Therapy in Elderly Patients with COVID-19 and ARDS [PDF]
, 2020 Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide. High-flow nasal cannula therapy (HFNC) is a major oxygen supporting therapy for severely ill patients, but information regarding the timing of HFNC application is scarce, especially in ...
Sun, Xiaocong +17 more
core +1 more source
Scientific Reports, 2021 The high-flow nasal cannula (HFNC) is a useful treatment modality for acute hypoxemic respiratory failure (AHRF) in children. We compared the ability of the oxygen saturation to fraction of inspired oxygen ratio (S/F) and arterial oxygen partial pressure
Ga Eun Kim +9 more
doaj +1 more source
Hospital mortality and survival according to duration of HFNC (days).
, 2022 Hospital mortality and survival according to duration of HFNC (days).
Marion Faucher (4281526) +10 more
core +1 more source
Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19
Gülhane Tıp Dergisi, 2022 Oxygen (O2) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19). High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities.
Kristin Purnama Dewi +4 more
doaj +1 more source
Comparison of HFNC ventilation systems [PDF]
, 2020 Vysokoprůtoková zvlhčená nosní kanyla (HFNC, High flow Nasal Cannula) je neinvazivní metoda kyslíkové terapie, kdy je zvlhčená a ohřátá směs plynů podávána nosní kanylou spontánně dýchajícímu pacientovi.
Michaela Soukopová
core